MENU
+Compare
PSIL
ETF ticker: NYSE ARCA
AS OF
Feb 21, 04:58 PM (EDT)
Price
$13.65
Change
-$0.37 (-2.64%)
Net Assets
10.37M

PSIL stock forecast, quote, news & analysis

PSIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for PSIL with price predictions
Feb 20, 2025

PSIL in +1.93% Uptrend, rising for three consecutive days on February 14, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PSIL advanced for three days, in of 168 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Aroon Indicator entered an Uptrend today. In of 93 cases where PSIL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PSIL moved out of overbought territory on February 07, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator moved out of overbought territory. In of the 14 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on February 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PSIL as a result. In of 54 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PSIL turned negative on February 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 26 similar instances when the indicator turned negative. In of the 26 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PSIL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PSIL broke above its upper Bollinger Band on February 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intra-Cellular Therapies (NASDAQ:ITCI).

Industry description

The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

Market Cap

The average market capitalization across the AdvisorShares Psychedelics ETF ETF is 926.86M. The market cap for tickers in the group ranges from 226.59K to 6.7B. ITCI holds the highest valuation in this group at 6.7B. The lowest valued company is SEEL at 226.59K.

High and low price notable news

The average weekly price growth across all stocks in the AdvisorShares Psychedelics ETF ETF was 2%. For the same ETF, the average monthly price growth was 42%, and the average quarterly price growth was 3,496%. PBM experienced the highest price growth at 7%, while DRUG experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the AdvisorShares Psychedelics ETF ETF was -48%. For the same stocks of the ETF, the average monthly volume growth was -6% and the average quarterly volume growth was 235%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 85
Price Growth Rating: 59
SMR Rating: 93
Profit Risk Rating: 87
Seasonality Score: -48 (-100 ... +100)
View a ticker or compare two or three
PSIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category MiscellaneousSector

Profile
Fundamentals
Details
Category
Miscellaneous Sector
Address
AdvisorShares Trust Suite 7003 Bethesda Metro CenterBethesda
Phone
(202) 684-6383
Web
www.advisorshares.com